Biotech News
Nautilus Biotechnology Reports Third Quarter 2026 Financial Results
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026.
